Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis
Current Good Manufacturing Practices (cGMPs) refers to the regulations enforced by the FDA. The cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.
Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. This formal system of controls at a pharmaceutical company, if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors. This assures that drug products meet their quality standards.
The cGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically sound design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement.
- Use of RFID in serialized unique packaging numbering to authenticate and check for recall/expiry status.
- Use of X-ray and metal detection systems to detect glass, stone, bone, rubber and other contaminants
- Use of checkweighers and sorters
- Use of baggers capable of handling, opening and sealing bags manufactured from specialist sterile films and papers.
- Use of quality control labeling systems
It is important to note that cGMPs are minimum requirements. Many pharmaceutical manufacturers are already implementing comprehensive, modern quality systems and risk management approaches that exceed these minimum standards. This is important because a consumer cannot detect through smell, touch, or sight if a drug product is safe or if it will work.
Manufacturing, Packaging & Detailing Industry Research & Market Reports
-
Pharmaceuticals Industry Forecasts - China Focus
... have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the ... Read More
-
Global Pharmaceutical Excipients Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
New US Administration: Looming Tariffs on Pharma Timelines
... implemented a series of tariff measures aimed at reducing the trade deficit. To date, key outcomes have included - Imposition of a 10% global baseline tariff Introduction of a reciprocal tariff framework Significant tariffs on ... Read More
-
Geopolitical, Macroeconomic, & Regulatory Changes Impacting the Pharmaceutical Industry
... industry. To date, key outcomes have included - Leadership changes across the Department of Health and Human Services (HHS) Major cuts across key departments and health programs Additional regulations that may curb investments Introduction of ... Read More
-
UK Veterinary Medicine Market Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceutical), By Animal Type (Production, Companion), By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2025 - 2030
... 2030, according to a new report by Grand View Research, Inc. This growth can be attributed to the novel product development in veterinary medicine, the rise in livestock population and increasing pet ownership rates, and ... Read More
-
Brand-Name Pharmaceutical Manufacturing in Canada - Industry Market Research Report
... losing their patent protection, many companies have streamlined their operations. By forming networks with public or private companies and academic institutions, brand-name pharmaceutical manufacturers have been able to share research and development costs. This trend ... Read More
-
Global Pharmaceuticals & Medicine Manufacturing - Industry Market Research Report
... Global Pharmaceuticals and Medicine Manufacturing industry. Many manufacturers have also tapped into regional demand for pharmaceuticals that may differ from developed markets and have expanded their global presence to tap into regional market needs and ... Read More
-
2025 Global: High Performance Liquid Chromatography (Hplc) In Pharmaceutical Market - Innovative Markets Forecast (2031) report
... provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope ... Read More
-
2025 Global: Efficacy Testing Market - Innovative Markets Forecast (2031) report
... forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market research ... Read More
-
Contract Research Organizations in the US - Industry Market Research Report
... and development investment, frustratingly high clinical trial costs and an uptick in patent expirations have driven pharmaceutical companies to outsource clinical trial management. These factors have pushed CRO revenue upward at a CAGR of 8.2% ... Read More
-
Pharmaceuticals Wholesaling in the US - Industry Market Research Report
... growth, as individuals generally require and purchase more medications as they get older. As a result, revenue is expected to increase at a CAGR of 5.3% to $1.3 trillion over the five years to 2023. ... Read More
-
2025 Global: Dexlansoprazole Market - Innovative Markets Forecast (2031) report
... based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market research publisher ... Read More
-
2025 Global: Heparin Active Pharmaceutical Ingredients Market - Innovative Markets Forecast (2031) report
... accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only ... Read More
-
2025 Global: Fill-Finish Pharmaceutical Contract Manufacturing Market - Innovative Markets Forecast (2031) report
... accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only ... Read More
-
2025 Global: Hydroxychloroquine Sulfate Tablets Market - Innovative Markets Forecast (2031) report
... industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market ... Read More
-
2025 Global: Formulation Additives Market - Innovative Markets Forecast (2031) report
... forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market research ... Read More
-
Pharmaceuticals Packing & Labeling Services in the US - Industry Market Research Report
... These companies need to outsource their services to packaging and labeling companies due to the very strict regulations from the FDA and other US regulatory watchdogs. Shifting age demographic have also provided strong downstream demand ... Read More
-
2025 Global: High Potency Api Contract Manufacturing Market - Innovative Markets Forecast (2031) report
... most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the ... Read More
-
Generic Pharmaceutical Manufacturing in the US - Industry Market Research Report
... competition from foreign companies. Over the past five years, revenue has grown at a CAGR of 0.9% to $53.8 billion, which includes a 14.2% increase in 2023 alone. Unlike brand name drug manufacturers, companies in ... Read More
-
Biotechnology Product Manufacturing
... the US), as well as Bayer and Merck Group (both based in Germany), CSL (Australia), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). COMPETITIVE LANDSCAPE Biotech ... Read More
-
Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report
... Given increasing price scrutiny, competition from generics, intensifying market competition among brand-name producers and rising research and development expenses, many manufacturers have shifted their strategic focus to more lucrative therapy areas, such as rare diseases ... Read More
-
Financial Analysis and Multi-Year Benchmarking: West Pharmaceutical Services Inc (WST:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... forWest Pharmaceutical Services Inc (WST:NYS) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for West Pharmaceutical Services Inc (WST:NYS) includes growth forecast for ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Amphastar Pharmaceutical Inc (AMPH:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Pharmaceutical Inc (AMPH:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for Amphastar Pharmaceutical Inc (AMPH:NAS) includes growth forecast for its primary industry ... Read More
-
Biological Product Manufacturing - 2025 U.S. Market Research Report with Updated Recession Risk & Tariff Analysis & Forecasts
... report is packed with insightful data sets and forecasts to give you a comprehensive understanding of the industry including historical and forecasted industry size, growth, tariff impact analysis, product line breakdown, profitability, financial ratios, 31 ... Read More
-
Pharmaceutical Manufacturing - 2025 U.S. Market Research Report with Updated Recession Risk & Tariff Analysis & Forecasts
... is packed with insightful data sets and forecasts to give you a comprehensive understanding of the industry including historical and forecasted industry size, growth, tariff impact analysis, product line breakdown, profitability, financial ratios, 31 balance ... Read More